Broadfin Capital’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-200,000
Closed -$424K 57
2018
Q3
$424K Buy
+200,000
New +$424K 0.06% 43
2017
Q2
Hold
0
62
2017
Q1
Hold
0
66